SCHEMBL5165428

SCHEMBL5165428

CC(C)CCCC(C)CCCC(C)CCCC(C)CCNC(=O)NCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.47
LMNA P02545 1/20 0.45
EPHX1 P07099 3/20 0.39
PTPN1 P18031 2/20 0.39
ANPEP P15144 2/20 0.38
RNPEP Q9H4A4 2/20 0.38
DNPEP Q9ULA0 1/20 0.38
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
CNR1 P21554 2/20 0.35
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62131 0.81 BLM (0.46) BLMLMNAPTPN1MEN1KMT2A
SCHEMBL5144765 0.78 BLM (0.50) BLMLMNAPTPN1ANPEPRNPEP
SCHEMBL5144576 0.78 BLM (0.50) BLMLMNAPTPN1ANPEPRNPEP
SCHEMBL11501644 0.77 LMNA (0.52) BLMLMNAPTPN1MEN1KMT2A
SCHEMBL27656888 0.77 BLM (0.42) BLMLMNAEPHX1PTPN1ANPEP
SCHEMBL11168376 0.76 EPHX1 (0.53) BLMEPHX1ANPEPRNPEPDNPEP
SCHEMBL2824432 0.76 ANPEP (0.55) LMNAEPHX1ANPEPRNPEPDNPEP
SCHEMBL12164496 0.75 BLM (0.47) BLMLMNAPTPN1ANPEPRNPEP
SCHEMBL5144491 0.75 BLM (0.43) BLMLMNAPTPN1ANPEPRNPEP
SCHEMBL12164429 0.74 BLM (0.46) BLMLMNAPTPN1ANPEPRNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101538200-A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants FH FAULDING & CO LTD (AU) 2009-09-23 CN disclosed
EP-1534669-A4 UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS MAYNE PHARMA INT PTY LTD (AU) 2007-03-14 EP disclosed
US-20050249665-A1 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants DBL AUSTRALIA PTY LTD. (AU) 2005-11-10 US disclosed
CN-1694865-A Urea, glycerate and hydroxylamine headed hydrocarbon chain lyotropic phase forming surfactants DBL AUSTRALIA PTY LTD (AU) 2005-11-09 CN disclosed
EP-1534669-A1 UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS DBL Australia PTY. LTD. (AU) 2005-06-01 EP disclosed
WO-2004022530-A1 UREA-, GLYCERATE- AND, HYDROXYAMIDE-HEADED HYDROCARBON CHAIN LYOTROPIC PHASES FORMING SURFACTANTS DBL AUSTRALIA PTY LTD (AU) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050249665-A1 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants LIPA, HDHD5, UGCG BLM 1559/4885LMNA 208/4885EPHX1 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.